| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...751397L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0051397 |
| P932 | PMC publication ID | 3519586 |
| P698 | PubMed publication ID | 23251518 |
| P5875 | ResearchGate publication ID | 233950157 |
| P50 | author | Antonio Bertoletti | Q37828529 |
| P2093 | author name string | Yin Hoe Yau | |
| David M Kranz | |||
| Adam J Gehring | |||
| Gijsbert M Grotenbreg | |||
| Anneta Naidoo | |||
| Zi Zong Ho | |||
| Gladys Yeo | |||
| Jianrong L Low | |||
| Susana G Shochat | |||
| P2860 | cites work | Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor | Q27643966 |
| Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers | Q27649766 | ||
| How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide | Q27651585 | ||
| An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex | Q27733448 | ||
| Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 | Q27733853 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction | Q28914743 | ||
| How TCRs bind MHCs, peptides, and coreceptors | Q29619572 | ||
| Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes | Q30787903 | ||
| In vitro evolution of a T cell receptor with high affinity for peptide/MHC. | Q30861962 | ||
| Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses | Q33652450 | ||
| The impact of TCR-binding properties and antigen presentation format on T cell responsiveness | Q33737674 | ||
| Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads | Q33934932 | ||
| Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? | Q33970966 | ||
| Domains in cell plasma membranes investigated by near-field scanning optical microscopy | Q34167717 | ||
| Monoclonal TCR-redirected tumor cell killing. | Q34273053 | ||
| Cutting edge: Evidence for a dynamically driven T cell signaling mechanism. | Q34275752 | ||
| Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling | Q34368920 | ||
| Human TCR-binding affinity is governed by MHC class restriction | Q34620378 | ||
| Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody | Q34741725 | ||
| T cell receptor specificity for major histocompatibility complex proteins | Q35150430 | ||
| Making sense of mass destruction: quantitating MHC class I antigen presentation | Q35597106 | ||
| Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs | Q35612835 | ||
| The level of viral antigen presented by hepatocytes influences CD8 T-cell function. | Q35784981 | ||
| Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness | Q36080586 | ||
| Breaking the affinity ceiling for antibodies and T cell receptors | Q36113815 | ||
| Directed evolution of human T-cell receptors with picomolar affinities by phage display. | Q51538190 | ||
| Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity. | Q51594643 | ||
| Stable, soluble T-cell receptor molecules for crystallization and therapeutics | Q51812335 | ||
| A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3. | Q52941721 | ||
| Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. | Q53631492 | ||
| Design and use of conditional MHC class I ligands. | Q53637625 | ||
| Binding properties and solubility of single-chain T cell receptors expressed in E. coli. | Q54587478 | ||
| How do cytotoxic lymphocytes kill their targets? | Q57720900 | ||
| Generation of peptide–MHC class I complexes through UV-mediated ligand exchange | Q60634999 | ||
| Monoclonal antibody detection of a major self peptide. MHC class II complex | Q67896783 | ||
| Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody | Q73479961 | ||
| How the T cell receptor sees antigen--a structural view | Q36226908 | ||
| Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors | Q36398857 | ||
| Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 | Q36499204 | ||
| Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes | Q36633085 | ||
| Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions | Q36878776 | ||
| Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis | Q36975877 | ||
| The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens | Q36994605 | ||
| Tricks with tetramers: how to get the most from multimeric peptide-MHC. | Q37363261 | ||
| Human hepatocyte transplantation: current experience and future challenges. | Q37724582 | ||
| Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines | Q39621915 | ||
| The T cell receptor | Q39682077 | ||
| Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells? | Q39930758 | ||
| Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines | Q40065187 | ||
| Clustering class I MHC modulates sensitivity of T cell recognition | Q40278155 | ||
| Visualization of p53(264-272)/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor | Q40313100 | ||
| Peptides naturally presented by MHC class I molecules | Q40898177 | ||
| The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies | Q40930624 | ||
| Clustering of class I HLA molecules on the surfaces of activated and transformed human cells | Q41476000 | ||
| Low Affinity Interaction of Peptide-MHC Complexes with T Cell Receptors | Q41652382 | ||
| Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies | Q45357002 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e51397 | |
| P577 | publication date | 2012-12-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes | |
| P478 | volume | 7 |
Search more.